Furthermore, these data suggest that by using CK20 RT-qPCR for CTC detection and enumeration approach (e.g., during long-term follow-up), a molecular MRD monitoring might be feasible in CRC patients allowing earlier detection and therapy decision making in relapse situations. This evidence concerns the gene KRT20 and colorectal carcinoma.